DE10112325A1 - Lagerstabile Fertiginfusionslösungen des Paracetamols - Google Patents

Lagerstabile Fertiginfusionslösungen des Paracetamols

Info

Publication number
DE10112325A1
DE10112325A1 DE10112325A DE10112325A DE10112325A1 DE 10112325 A1 DE10112325 A1 DE 10112325A1 DE 10112325 A DE10112325 A DE 10112325A DE 10112325 A DE10112325 A DE 10112325A DE 10112325 A1 DE10112325 A1 DE 10112325A1
Authority
DE
Germany
Prior art keywords
solution according
solution
paracetamol
per liter
cysteine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10112325A
Other languages
German (de)
English (en)
Inventor
Bernd Eschenbach
Hans-Joerg Mueller
Klaus Sommermyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SOMMERMEYER, KLAUS, DR., 61191 ROSBACH, DE
Original Assignee
Fresenius Kabi Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Deutschland GmbH filed Critical Fresenius Kabi Deutschland GmbH
Priority to DE10112325A priority Critical patent/DE10112325A1/de
Priority to EP02724223A priority patent/EP1372628A2/fr
Priority to AU2002254942A priority patent/AU2002254942A1/en
Priority to PCT/EP2002/002696 priority patent/WO2002072080A2/fr
Publication of DE10112325A1 publication Critical patent/DE10112325A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE10112325A 2001-03-13 2001-03-13 Lagerstabile Fertiginfusionslösungen des Paracetamols Withdrawn DE10112325A1 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE10112325A DE10112325A1 (de) 2001-03-13 2001-03-13 Lagerstabile Fertiginfusionslösungen des Paracetamols
EP02724223A EP1372628A2 (fr) 2001-03-13 2002-03-12 Solutions de paracetamol stables au stockage et pretes a la perfusion
AU2002254942A AU2002254942A1 (en) 2001-03-13 2002-03-12 Paracetamol solutions which are stable in storage and ready for infusion
PCT/EP2002/002696 WO2002072080A2 (fr) 2001-03-13 2002-03-12 Solutions de paracetamol stables au stockage et pretes a la perfusion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10112325A DE10112325A1 (de) 2001-03-13 2001-03-13 Lagerstabile Fertiginfusionslösungen des Paracetamols

Publications (1)

Publication Number Publication Date
DE10112325A1 true DE10112325A1 (de) 2002-10-02

Family

ID=7677473

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10112325A Withdrawn DE10112325A1 (de) 2001-03-13 2001-03-13 Lagerstabile Fertiginfusionslösungen des Paracetamols

Country Status (4)

Country Link
EP (1) EP1372628A2 (fr)
AU (1) AU2002254942A1 (fr)
DE (1) DE10112325A1 (fr)
WO (1) WO2002072080A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112782332A (zh) * 2021-02-04 2021-05-11 深圳市药品检验研究院（深圳市医疗器械检测中心） 一种对乙酰氨基酚药品中对氨基酚杂质的hplc检测方法

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566401B2 (en) 2001-03-30 2003-05-20 The Board Of Trustees Of The Leland Stanford Junior University N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
ITMI20012135A1 (it) 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
FR2851164B1 (fr) * 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
DE102005037653A1 (de) 2005-08-05 2007-02-15 Theraselect Gmbh Stabile, flüssige Formulierung von Paracetamol
JP4929352B2 (ja) 2006-07-18 2012-05-09 スペイン ファルマ ソシエダ アノニマ 注入可能なパラセタモール液剤
EP1992334A1 (fr) * 2007-05-08 2008-11-19 Docpharma NV/SA Formule stable pour le stockage de médicament phénolique sensible à l'oxydation, spécialement le paracétamol, et qui comprend une solution de médicament aqueuse désoxygénée par le processus de fabrication à température contrôlée de la formule
US20110015273A1 (en) * 2008-01-17 2011-01-20 Rajnarayana Kandhagatla Stable pharmaceutical aqueous compositions
EP2243477A1 (fr) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracétamol destiné à l'administration parentérale
US8404748B2 (en) 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
EP2464332B1 (fr) 2009-08-13 2016-03-02 Neogen N.V. Formulation de paracétamol en solution aqueuse stable en stockage
CN102711726A (zh) * 2009-12-10 2012-10-03 特克尼梅德医疗技术股份公司 用于制备扑热息痛稳定液体制剂的方法和组合物
EP2377516B1 (fr) * 2010-04-14 2012-06-20 B. Braun Melsungen AG Composition de paracétamol
EP2672955A1 (fr) 2011-02-10 2013-12-18 Neogen N.V. Formulation de paracétamol en solution aqueuse stable au stockage
JP6046057B2 (ja) 2011-03-04 2016-12-14 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 経口投与用タペンタドールの水性医薬製剤
ES2414557B1 (es) 2012-01-16 2014-06-10 Novocat Farma, S.A. Composición acuosa de paracetamol para inyección
ITMI20121154A1 (it) * 2012-06-29 2013-12-30 Sint Sa Soluzione iniettabile di acetaminofene per la somministrazione spinale
EA028075B1 (ru) * 2014-04-29 2017-10-31 Мыкола Ивановыч ГУМЕНЮК Фармацевтическая композиция
WO2016156147A1 (fr) 2015-03-27 2016-10-06 Grünenthal GmbH Formulation stable pour l'administration parentérale de tapentadol
US10898452B2 (en) 2016-09-23 2021-01-26 Gruenenthal Gmbh Stable formulation for parenteral administration of Tapentadol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
EP0916347B1 (fr) * 1997-11-18 2003-02-19 Uni-Pharma Kleon Tsetis A.B.E.E., Farmakeftika Ergastiria Solutions pharmaceutiques injectables contenant du paracétamol et des associations du paracétamol avec d'autres substances actives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112782332A (zh) * 2021-02-04 2021-05-11 深圳市药品检验研究院（深圳市医疗器械检测中心） 一种对乙酰氨基酚药品中对氨基酚杂质的hplc检测方法

Also Published As

Publication number Publication date
AU2002254942A1 (en) 2002-09-24
EP1372628A2 (fr) 2004-01-02
WO2002072080A3 (fr) 2002-11-28
WO2002072080A2 (fr) 2002-09-19

Similar Documents

Publication Publication Date Title
DE10112325A1 (de) Lagerstabile Fertiginfusionslösungen des Paracetamols
DE69722580T2 (de) Neue stabile flüssige paracetamolmittel und verfahren zu deren herstellung
DE60121016T2 (de) Polymere mizelle mit darin eingeschlossenem cisplatin und ihre verwendung
DE602005002653T2 (de) Stabilisierte zusammensetzungen mit einem therapeutischen wirkstoff; zitronensäure oder einer konjugierten base und chlordioxid
EP1206281B1 (fr) Formulation comprenant moxifloxacin et chlorure de sodium
DE602005002495T2 (de) Injizierbare Formulierung mit Natriumdiclofenac, Beta-Cyclodextrin und einem Polysorbat
EP1255557B1 (fr) Preparation pharmaceutique stable, pouvant etre utilisee par voie nasale, orale ou sublinguale contenant de la desmopressine
EP1752139A1 (fr) Formulation stable et liquide de la paracétamol
DE3621844C2 (de) Injizierbare, Doxorubicin-enthaltende Lösung und Verfahren zur Herstellung derselben
DE60305687T2 (de) Wässrige injizierbare Suspensionen für Tiere enthaltend Florfenicol
WO2001078732A1 (fr) Solution pour perfusion stable au stockage a base de ciprofloxacine
EP1206244B1 (fr) Composition pharmaceutique aqueuse a base de moxifloxacine ou de ses sels
EP2626068B1 (fr) Paracétamol destiné à l'administration parentérale
DE69300017T2 (de) Wässrige pharmazeutische Zubereitung von Natriumcromoglykat.
DE60113255T2 (de) Neue formulierungen von -g(a)-2,4-disulfophenyl-n-tert-butylnitron
DE3752368T2 (de) Doxorubicin enthaltende einspritzbare gebrauchsfertige Lösungen gegen Krebs
DE60101979T2 (de) Lösung enthaltend N-[O-(p-pivaloyloxybenzenesulfonylamino)benzoyl]glyzin Mononatriumsalz Tetrahydrat und diese Lösung enthaltendes Arzneimittel
DE60001489T2 (de) Pharmazeutische zubereitung für die intravenöse oder intramuskuläre verabreichung von octreotid
EP1073469A1 (fr) Solutions stables de mitoxantrone
AT401469B (de) Pharmazeutische wässrige lösung zur parenteralen anwendung enthaltend einen in situ gebildeten komplex von einem alkaloid mit bis-indol-gerüst, sowie verfahren zu deren herstellung
WO2002026233A1 (fr) Solution pour perfusion de ciprofloxacine stable au stockage et a teneur reduite en acide
DE602004012731T2 (de) Zubereitungen mit verzögerter freigabe enthaltend zink, und herstellung derselben
DE2546474A1 (de) Injizierbares pharmazeutisches thyroxinpraeparat und verfahren zu dessen herstellung
DE2723936A1 (de) Ophthalmische loesung fuer die glaucom-behandlung
DE2721034C2 (fr)

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8127 New person/name/address of the applicant

Owner name: SOMMERMEYER, KLAUS, DR., 61191 ROSBACH, DE

8130 Withdrawal